CARDIOVASCULAR DISEASES AND TYPE 2 DIABETES MELLITUS: HIGH HEART FAILURE RISK AND LOW RATE CONTRAINDICATIONS TO SGLT2I ArticleMedovchshikov V.V., Yeshniyazov N., Khasanova E., Zholdin B., Kurmanalina G., Amanova A., Kobalava Z.EUROPEAN JOURNAL OF HEART FAILURE. Том 26. 2024. С. 563-563
PRESCRIBING SGLT2 INHIBITORS IN ACUTE HEART FAILURE: CONSIDERATIONS FOR DYSGLYCEMIA STATUS, HEART FAILURE PHENOTYPE, AND KIDNEY FUNCTION ArticleMedovchshikov V.V., Yeshniyazov N., Khasanova E., Zholdin B., Kurmanalina G., Kushimova D., Tleumagambetova B., Amanova A., Kobalava Z.EUROPEAN JOURNAL OF HEART FAILURE. Том 26. 2024. С. 591-592
